According to Organovo's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 49.122. At the end of 2023 the company had a P/S ratio of 40.5.
Year | P/S ratio | Change |
---|---|---|
2023 | 40.5 | 459.55% |
2022 | 7.24 | |
2021 | N/A | |
2020 | N/A | -100% |
2019 | 16.1 | -49.66% |
2018 | 32.1 | -3.56% |
2017 | 33.2 | -62.56% |
2016 | 88.8 | -53.62% |
2015 | 191 | -86.25% |
2014 | > 1000 | -22.2% |
2013 | > 1000 | 1307.33% |
2012 | 127 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
General Electric GE | 2.54 | -94.84% | ๐บ๐ธ USA |
3M MMM | 1.78 | -96.38% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | 19.2 | -60.89% | ๐บ๐ธ USA |
United Therapeutics UTHR | 4.83 | -90.16% | ๐บ๐ธ USA |
Stratasys SSYS | 1.08 | -97.81% | ๐ฎ๐ฑ Israel |
3D Systems DDD | 0.9930 | -97.98% | ๐บ๐ธ USA |